- Home
- VEEA vs ATOS Comparison
VEEA vs ATOS Comparison
Compare VEEA & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEA
- ATOS
- Stock Information
- Founded
- VEEA 2014
- ATOS 2009
- Country
- VEEA United States
- ATOS United States
- Employees
- VEEA N/A
- ATOS N/A
- Industry
- VEEA
- ATOS Biotechnology: Pharmaceutical Preparations
- Sector
- VEEA
- ATOS Health Care
- Exchange
- VEEA NYSE
- ATOS Nasdaq
- Market Cap
- VEEA 112.2M
- ATOS 96.8M
- IPO Year
- VEEA N/A
- ATOS 2012
- Fundamental
- Price
- VEEA $1.63
- ATOS $0.62
- Analyst Decision
- VEEA
- ATOS Strong Buy
- Analyst Count
- VEEA 0
- ATOS 3
- Target Price
- VEEA N/A
- ATOS $7.00
- AVG Volume (30 Days)
- VEEA 13.8K
- ATOS 699.0K
- Earning Date
- VEEA 05-23-2025
- ATOS 05-12-2025
- Dividend Yield
- VEEA N/A
- ATOS N/A
- EPS Growth
- VEEA N/A
- ATOS N/A
- EPS
- VEEA N/A
- ATOS N/A
- Revenue
- VEEA $141,760.00
- ATOS N/A
- Revenue This Year
- VEEA N/A
- ATOS N/A
- Revenue Next Year
- VEEA N/A
- ATOS N/A
- P/E Ratio
- VEEA N/A
- ATOS N/A
- Revenue Growth
- VEEA N/A
- ATOS N/A
- 52 Week Low
- VEEA $1.33
- ATOS $0.55
- 52 Week High
- VEEA $18.56
- ATOS $1.81
- Technical
- Relative Strength Index (RSI)
- VEEA N/A
- ATOS 42.51
- Support Level
- VEEA N/A
- ATOS $0.56
- Resistance Level
- VEEA N/A
- ATOS $0.67
- Average True Range (ATR)
- VEEA 0.00
- ATOS 0.06
- MACD
- VEEA 0.00
- ATOS 0.00
- Stochastic Oscillator
- VEEA 0.00
- ATOS 43.75
About VEEA VEEA INC
Veea Inc is a company providing edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades. It has first-in-class VeeaHub smart computing hubs integrate a full range of connectivity options, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.